Pediatric ECMO for severe quinidine cardiotoxicity.
We report the use of extracorporeal membrane oxygenation (ECMO) to establish and maintain cardiovascular stability in a 16 month old with refractory bradydysrrhythmias and hypotension after an acute overdose of quinidine. He underwent an 11-day course of ECMO and was discharged with normal neurologic function. This case illustrates the role ECMO can play in the treatment of profound cardiovascular collapse caused by toxic ingestions. To be optimally effective, management of such patients must be anticipatory.
Tecklenburg
F W
FW
Children's Hospital, Medical University of South Carolina, Charleston 29425-3305, USA.
Thomas
N J
NJ
Webb
S A
SA
Case
C
C
Habib
D M
DM
D000889:Anti-Arrhythmia Agents / Q000506:poisoning*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000628:therapy; D001630:Bezoars / Q000209:etiology / Q000628:therapy; D003692:Delayed-Action Preparations; D062787:Drug Overdose / Q000628:therapy; D015199:Extracorporeal Membrane Oxygenation; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007223:Infant; D008297:Male; D011802:Quinidine / Q000506:poisoning*; D013270:Stomach
D000889:Anti-Arrhythmia Agents; D003692:Delayed-Action Preparations; D011802:Quinidine